Héma-Québec, Research and Development, Quebec City, Canada.
Héma-Québec, Research and Development, Quebec City, Canada; Laboratory for Biomaterials and Bioengineering, Department of Mining-Metallurgical and Materials Engineering & University Hospital Research Center, Laval University, Quebec City, Canada.
Exp Hematol. 2014 Sep;42(9):741-52.e1. doi: 10.1016/j.exphem.2014.04.009. Epub 2014 May 2.
Strategies to enhance the expansion of umbilical cord blood hematopoietic stem and progenitor cells (HSPCs) are crucial to enable their widespread application to adults and to overcome important limitations, such as delayed engraftment. Osteoblasts regulate HSPCs under steady-state and also under stress conditions, when HSPCs undergo numerous cycles of expansion. We hypothesized that osteoblasts could provide better stimulation for the expansion of multipotent HSPCs and subsequent hematopoietic recovery than mesenchymal stromal cells. Hence, we assessed the growth and engraftment modulatory activities of mesenchymal stromal cell-derived osteoblasts (M-OSTs) on hematopoietic progenitors. Mesenchymal stromal cells and M-OSTs favored the maintenance of CD34(+) cells. The expansion of cord blood CD34(+) cells and myeloid progenitors was highest in cultures supplemented with unfiltered M-OST-conditioned medium (M-OST CM). In addition, increased expression of cell surface receptors important for the homing of progenitors to the bone marrow, C-X-C chemokine receptor type 4 and lymphocyte function-associated antigen 1, was observed in CM-based cultures. Additionally, M-OST CM positively modulated the engraftment properties of expanded progenitors. Most notably, although human platelet levels remained steady in the first 2 weeks in mice transplanted with HSPCs expanded in standard medium, levels in mice transplanted with M-OST CM HSPCs rose continuously. Consistent with this, short-term human progenitor reconstitution was consistently greater in M-OST recipients. Finally, cytokine array-based profiling revealed increases in insulin-like growth factor binding protein 2, chemokines, and myeloid stimulating cytokines in M-OST CM. In conclusion, this study suggests that M-OSTs represent a new underappreciated source of feeder cells for the expansion of HSPCs with enhanced thrombopoietic activity.
策略以增强脐血造血干细胞和祖细胞(HSPCs)的扩增对于使它们广泛应用于成人并克服重要的限制因素(如延迟植入)至关重要。成骨细胞在稳态下和 HSPCs 经历多次扩增循环的应激条件下调节 HSPCs。我们假设成骨细胞可以为多能 HSPCs 的扩增和随后的造血恢复提供比间充质基质细胞更好的刺激。因此,我们评估了间充质基质细胞衍生的成骨细胞(M-OST)对造血祖细胞的生长和植入调节活性。间充质基质细胞和成骨细胞都有利于维持 CD34+细胞。在补充未过滤的 M-OST 条件培养基(M-OST CM)的培养物中,脐血 CD34+细胞和髓系祖细胞的扩增最高。此外,在基于 CM 的培养物中观察到对祖细胞归巢到骨髓很重要的细胞表面受体的表达增加,即 C-X-C 趋化因子受体 4 和淋巴细胞功能相关抗原 1。此外,M-OST CM 还正向调节扩增祖细胞的植入特性。值得注意的是,尽管在标准培养基中扩增的 HSPCs 移植到小鼠中的前 2 周内人血小板水平保持稳定,但在 M-OST CM HSPCs 移植到小鼠中的水平持续升高。与此一致,M-OST 受者中的短期人类祖细胞重建始终更大。最后,基于细胞因子阵列的分析显示 M-OST CM 中胰岛素样生长因子结合蛋白 2、趋化因子和髓样刺激细胞因子增加。总之,这项研究表明,M-OST 代表了一种新的未被充分认识的 HSPC 扩增饲养细胞来源,具有增强的促血小板生成活性。